The study
of proteomes extensively is known as proteomics. A group of proteins produced
by a biological entity is known as a proteome. For instance, a proteome can
belong to a species, for example, homo sapiens, or of an organ, for example,
the liver. A proteome isn’t regular; it varies from one cell to another and
changes over time. Partly, a proteome is a reflection of the basic
transcriptome, which can also be described as the entire range of messenger RNA
molecules present in an organism. Major propelling factors of growth in the proteomics
market include surging demand for personalized medicine, increasing
applications of proteomics in drug discovery, surge in demand for early
diagnosis and treatment of diseases, technical advancements, increase in birth
disorders and genetic disorders and the exponentially rising pharmaceutical and
biopharmaceutical markets. Few other factors favoring growth are development of
protein targeted treatments and precision molecular medicines for various
autoimmune diseases, development of mass spectrometry-based proteomics, and
development of molecular targets in malignancies. Rising focus of
biotechnological and pharmaceutical companies in research and development for discovering
new proteomics applications, development of new drugs and proteomics biomarker
discovery in various types of diseases such as cardiovascular diseases and
cancer is the key trend in the global proteomics market. Proteomics is highly
used in protein expression profiling, targeted protein quantitation, analysis
of interactions between proteins, and post-translational modification in various
segments of the pharmaceutical industry. Advanced proteomics solutions are having
extensive application in diagnostic services, drug discovery and other research
areas. Proteomics is a promising approach towards personalized medicine to
treat number of diseases, such as diabetes, fatty liver, obesity, neurological
diseases and cancer. In addition to the increasing incidence of cancer,
diabetes, and other possibly fatal diseases, there is a surge in disorders,
such as autism and Alzheimer's, which are significantly wanting in terms of
research and cure. Use of plasma proteomics method for proteomic biomarker
identification is related with challenges of patients' variation and high
dynamic range of plasma proteins. However, rising focus on specialty medicines owing
to technological advancements, advanced software, and tools such as IoT, data
analytics, big data, and artificial intelligence in the clinical research associated
to proteomics could create new opportunities for the proteomics market.
However, the high cost associated to instruments is likely to hamper the market
growth.
The field
of nanotechnology has been associated with various proteomics applications such
as phosphoproteomics/metal oxide nanoparticles, nanostructured surfaces for
protein separation and analytical detection of biomarker proteins
using array techniques. This has resulted in the emergence of nanoproteomics, a
science involving the application of proteomics techniques supported by
nanotechnology which is creating opportunity for the market growth.
The
global Proteomics Market is segregated on the basis of Equipment as Chromatography,
Mass Spectroscopy, Protein Microarray, X-ray Crystallography, Protein
Fractionation and Others. Based on Services the global Proteomics Market is
segmented in Laboratory Service and Data Analysis and Services. Based on Application
the global Proteomics Market is segmented in Drug Discovery, Clinical Diagnosis
and Others.
The
global Proteomics Market report provides geographic analysis covering regions,
such as Europe, North America, Asia Pacific, and Rest of The World. The Proteomics
Market for each region is further segmented for major countries including the
U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil,
South Africa, and others.
Competitive Analysis
Hoffmann-La
Roche Ltd, GENERAL ELECTRIC COMPANY, Bio-Rad Laboratories, Inc., Danaher, Siemens
Ltd. and others are among the major players in the global Proteomics Market.
The companies studied in terms of product strategy and various n several growth
and expansion strategies to gain a competitive edge in the market. The major
players not only follow value chain integration with business operations in
multiple stages of the value chain.
- In Feb
2021, Agilent Technologies Inc. introduced Agilent Dako SARS-CoV-2 IgG
Enzyme-Linked Immunosorbent Assay (ELISA) kit aimed for the qualitative
detection of immunoglobulin G (IgG) antibodies to SARS-CoV-2 in human serum or
plasma.
- In Dec
2020, Thermo Fisher Scientific acquired Phitonex, Inc. Phitonex's product
offering will allow Thermo Fisher to provide higher flow cytometry and imaging
multiplexing abilities to meet evolving customer requirements in protein and
cell analysis research.
The global Proteomics Market has been segmented as
below:
Proteomics
Market, By Equipment
- Chromatography
- Mass Spectroscopy
- Protein Microarray
- X-ray Crystallography
- Protein Fractionation
- Others
Proteomics
Market, By Services
- Data Analysis and Services
Proteomics
Market, By Application
- Drug Discovery
- Clinical Diagnosis
- Others
Proteomics
Market, By Region
- Europe
- North America
- Asia Pacific
- Rest of The World
Proteomics
Market, By Company
- Hoffmann-La Roche Ltd
- GENERAL ELECTRIC COMPANY
- Bio-Rad Laboratories, Inc.
- Danaher
- Siemens Ltd.
- Thermo Fisher Scientific Inc. Inc.
- Agilent Technologies, Inc.
- Genzyme Corporation
- Biognosys AG
- Bruker
- Luminex Corporation
- Merck KGaA
- PerkinElmer Inc.
- WATERS
- Caprion Biosciences Inc.
- Fios Genomics Ltd.
- Poochon Scientific, LLC
- Applied Biomics, Inc.
- GENEWIZ
- Proteome Factory AG
The
report covers the below scope:
- Global Proteomics Market sizes from
2020 to 2026, along with CAGR for 2020-2026
- Market size comparison for 2019 vs
2026, with actual data for 2019, estimates for 2019 and forecast from 2020 to
2026
- Global Proteomics Market trends,
covering comprehensive range of consumer trends & manufacturer trends
- Value chain analysis covering
participants from raw material suppliers to the downstream buyer in the global Proteomics
Market
- Major market opportunities and
challenges in forecast timeframe to be focused
- Competitive landscape with analysis
on competition pattern, portfolio comparisons, development trends and strategic
management
- Comprehensive company profiles of
the key industry players
The
years considered for the study are as follows:
- Base year - 2019
- Estimated year - 2019
- Projected year - 2020
- Forecast period - 2021 to 2026
Report
Scope:
The global Proteomics Market report scope includes
detailed study covering underlying factors influencing the industry trends. The
report covers analysis on regional and country level market dynamics. The scope
also covers competitive overview providing company market shares along with
company profiles for major revenue contributing companies. The report scope
includes detailed competitive outlook covering market shares and profiles key
participants in the global Proteomics Market share. Major industry players with
significant revenue share include Hoffmann-La Roche Ltd, GENERAL
ELECTRIC COMPANY, Bio-Rad Laboratories, Inc., Danaher, Siemens Ltd. and others.
Why to
Buy this Report:
- Gain detailed insights on the Proteomics
industry trends
- Find complete analysis on the
market status
- Identify the Proteomics Market
opportunities and growth segments
- Analyse competitive dynamics by
evaluating business segments & product portfolios
- Facilitate strategy planning and
industry dynamics to enhance decision making
Target
Audience:
- The report targeted towards the existing players in
the industry is as follows:
- Market Manufacturers/Service
Providers
- Market Wholesale/Traders
- Investment and Financial
Institutions
Free
and Paid Customization based on the requirement